Lower Provider Volume is Associated with Higher Failure Rates for Endoscopic Retrograde Cholangiopancreatography
Overview
Authors
Affiliations
Background: Among physicians who perform endoscopic retrograde cholangiopancreatography (ERCP), the relationship between procedure volume and outcome is unknown.
Objective: Quantify the ERCP volume-outcome relationship by measuring provider-specific failure rates, hospitalization rates, and other quality measures.
Research Design: Retrospective cohort.
Subjects: A total of 16,968 ERCPs performed by 130 physicians between 2001 and 2011, identified in the Indiana Network for Patient Care.
Measures: Physicians were classified by their average annual Indiana Network for Patient Care volume and stratified into low (<25/y) and high (≥25/y). Outcomes included failed procedures, defined as repeat ERCP, percutaneous transhepatic cholangiography or surgical exploration of the bile duct≤7 days after the index procedure, hospitalization rates, and 30-day mortality.
Results: Among 15,514 index ERCPs, there were 1163 (7.5%) failures; the failure rate was higher among low (9.5%) compared with high volume (5.7%) providers (P<0.001). A second ERCP within 7 days (a subgroup of failure rate) occurred more frequently when the original ERCP was performed by a low-volume (4.1%) versus a high-volume physician (2.3%, P=0.013). Patients were more frequently hospitalized within 24 hours when the ERCP was performed by a low-volume (28.3%) versus high-volume physician (14.8%, P=0.002). Mortality within 30 days was similar (low=1.9%, high=1.9%). Among low-volume physicians and after adjusting, the odds of having a failed procedure decreased 3.3% (95% confidence interval, 1.6%-5.0%, P<0.001) with each additional ERCP performed per year.
Conclusions: Lower provider volume is associated with higher failure rate for ERCP, and greater need for postprocedure hospitalization.
On-site ERCP availability and cholangitis outcomes: Retrospective cohort study.
Khan R, Marchena-Romero K, Ismail M, Roberts S, Gimpaya N, Scaffidi M Endosc Int Open. 2025; 13:a24947333.
PMID: 39958657 PMC: 11827753. DOI: 10.1055/a-2494-7333.
Basida S, Dahiya D, Yousaf M, Basida B, Pinnam B, Gangwani M World J Gastrointest Endosc. 2024; 16(3):148-156.
PMID: 38577647 PMC: 10989256. DOI: 10.4253/wjge.v16.i3.148.
Ahmed W, Joshi D, Huggett M, Everett S, James M, Menon S Frontline Gastroenterol. 2024; 15(1):74-83.
PMID: 38487565 PMC: 10935540. DOI: 10.1136/flgastro-2023-102491.
Aloysius M, Goyal H, Nikumbh T, Shah N, Hammoud G, Mutha P World J Gastrointest Endosc. 2023; 15(11):641-648.
PMID: 38073762 PMC: 10698332. DOI: 10.4253/wjge.v15.i11.641.
Beaton D, Rutter M, Sharp L, Oppong K, Awadelkarim B, Everett S Frontline Gastroenterol. 2023; 14(5):384-391.
PMID: 37581181 PMC: 10423606. DOI: 10.1136/flgastro-2023-102424.